Clear Street’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Clear Street’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1	Closed	-$11	–	1171
2023 Q3	$11	Buy	+1	New	+$11	﹤0.01%	1082
2023 Q2	–	Sell	-84,180	Closed	-$879K	–	1462
2023 Q1	$879K	Buy	+84,180	New	+$872K	0.03%	71
2022 Q4	–	Sell	-1,116	Closed	-$11K	–	1333
2022 Q3	$11K	Buy	+1,116	New	+$11.2K	﹤0.01%	600

Clear Street's BIOS Position: Q4 2023 in Review

Clear Street sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 1 share — an estimated $11 sold.

Clear Street first reported a position in BIOS in Q3 2022 and held it in 3 quarters. The position peaked at $879K in Q1 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Clear Street reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Clear Street sold 1 BioPlus Acquisition Corp. Class A Ordinary Shares share in Q4 2023, an estimated $11.
Clear Street first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q3 2022 and held it in 3 quarters.
Clear Street's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $879K in Q1 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Clear Street's 13F filing for Q4 2023, filed 14 Feb 2024.